XML 65 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments Measured at Fair Value (Tables)
3 Months Ended
Mar. 29, 2014
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at March 29, 2014:

 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
70,910

 
$

 
$

 
$
70,910

Foreign exchange contracts
 

 
1,003

 

 
1,003

Contingent consideration
 

 

 
(11,606
)
 
(11,606
)
 
 
$
70,910

 
$
1,003

 
$
(11,606
)
 
$
60,307


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2013:

 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
69,857

 
$

 
$

 
$
69,857

Foreign exchange contracts
 

 
(654
)
 

 
(654
)
Contingent consideration
 

 

 
(5,845
)
 
(5,845
)
 
 
$
69,857

 
$
(654
)
 
$
(5,845
)
 
$
63,358

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table summarizes the Level 3 activity for the first quarter of 2014:

Balance as of December 31, 2013
$
(5,845
)
Fair value of initial contingent consideration
(5,853
)
Change in fair value of contingent consideration included in earnings
138

Foreign currency translation adjustment
(46
)
Balance as of March 29, 2014
$
(11,606
)
Available-for-sale Securities [Text Block]
The fair value of the company's available-for-sale securities at March 29, 2014 is as follows:

  
 
Marubun
 
WPG
 
Mutual Funds
Cost basis
 
$
10,016

 
$
10,798

 
$
15,690

Unrealized holding gain
 
1,957

 
26,521

 
5,928

Fair value
 
$
11,973

 
$
37,319

 
$
21,618



The fair value of the company's available-for-sale securities at December 31, 2013 is as follows:

 
 
Marubun
 
WPG
 
Mutual Funds
Cost basis
 
$
10,016

 
$
10,798

 
$
15,614

Unrealized holding gain
 
2,709

 
24,903

 
5,817

Fair value
 
$
12,725

 
$
35,701

 
$
21,431

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]
The fair values of derivative instruments in the company's consolidated balance sheets are as follows:

 
 
Asset (Liability) Derivatives
  
 
  
 
Fair Value
  
 
Balance Sheet
Location
 
March 29,
2014
 
December 31,
2013
Derivative instruments designated as hedges:
 
 
 
 
 
 
Foreign exchange contracts designated as cash flow hedges
 
Other current assets
 
$
253

 
$
368

Foreign exchange contracts designated as cash flow hedges
 
Accrued expenses
 
(510
)
 
(203
)
Total derivative instruments designated as hedging instruments
 
 
 
(257
)
 
165

Derivative instruments not designated as hedges:
 
 
 
 

 
 

Foreign exchange contracts
 
Other current assets
 
2,001

 
1,275

Foreign exchange contracts
 
Accrued expenses
 
(741
)
 
(2,094
)
Total derivative instruments not designated as hedging instruments
 
 
 
1,260

 
(819
)
Total
 
 
 
$
1,003

 
$
(654
)
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effect of derivative instruments on the company's consolidated statements of operations is as follows:

 
 
Gain (Loss) Recognized in Income
  
 
Quarter Ended
  
 
March 29,
2014
 
March 30,
2013
Derivative instruments not designated as hedges:
 
 
 
 
Foreign exchange contracts (a)
 
$
1,913

 
$
(1,134
)

 
Cash Flow Hedges
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
Quarter Ended March 29, 2014
 
 
 
Effective portion:
 
 
 
Gain (loss) recognized in other comprehensive income
$

 
$
(368
)
Gain (loss) reclassified into income
$
(161
)
 
$
136

Ineffective portion:
 
 
 
Gain (loss) recognized in income
$

 
$

 
 
 
 
Quarter Ended March 30, 2013
 
 
 
Effective portion:
 
 
 
Gain (loss) recognized in other comprehensive income
$
3,132

 
$
(59
)
Gain (loss) reclassified into income
$

 
$
252

Ineffective portion:
 
 
 
Gain (loss) recognized in income
$
292

 
$


(a)
The amount of gain (loss) recognized in income on derivatives is recorded in "Cost of sales" in the company's consolidated statements of operations.
(b)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations.
(c)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Cost of sales" in the company's consolidated statements of operations.